Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
2
Bearish filings
5
Named actors
7
Disclosed $ (bull / bear)
size unknown / $43K
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-01-02 | President and CEO Litton Mark James | sold | $18K | SEC ↗ |
| 2026-01-02 | CHIEF MEDICAL OFFICER San Martin Javier | sold | $11K | SEC ↗ |
| 2026-01-02 | CHIEF SCIENTIFIC OFFICER CHURCH KEVIN | sold | $6K | SEC ↗ |
| 2026-01-02 | General Counsel and CCO Worthington Mark | sold | $6K | SEC ↗ |
| 2026-01-02 | Chief Financial Officer Renninger Robert | sold | $2K | SEC ↗ |
| 2025-12-23 | 5%+ holder (13G) ACORN BIOVENTURES, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2025-11-14 | 5%+ holder (13G) Baselake Partners, LP | disclosed a passive stake (13G) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals